Sino Biopharmaceutical Ltd. announced that with effect from 20 April, 2015, the following changes in the Board composition and Board committees have taken place. Ms. Cheng Cheung Ling, who is an Executive Director of the Company, continues to be an Executive Director and be appointed as a member of the Executive Board Committee of the Company; Mr. Wang Shanchun, Mr. Tian Zhoushan and Ms. Li Mingqin be appointed
Executive Directors of the Company; Ms. Lu Hong be appointed as an Independent Non-executive Director and a member each of the Audit Committee, Remuneration Committee and Nomination Committee of the Company; Mr. Zhang Lu Fu be appointed as an Independent Non-executive Director, the
chairman of the Remuneration Committee and a member of the Nomination Committee of the Company; Mr. Zhang Baowen has resigned as Vice Chairman, an Executive Director and a member of the Executive Board Committee of the Company; Mr. Tao Huiqi and Mr. He Huiyu have resigned as Executive Directors of the Company; Ms. Li Jun has resigned as an Independent Non-executive Director and a member each of the Audit Committee, Remuneration Committee and Nomination Committee of the Company; and Mr. Mei Xingbao has resigned as an Independent Non-executive Director, the chairman of the Remuneration Committee and a member of the Nomination Committee of the Company.